With the FTC considering the pending merger of Walgreens and Rite-Aid, the consequences of pharmacies owning PBMs may once again be considered. It has been several years since FTC approved the CVS / Caremark merger, and the changes and consequences of that merger are now visible. It is imperative that these issues of potential conflicts of interest are revisited. For an excellent overview, read:
Big pharmacies are dismantling the industry that keeps US drug costs even sort-of under control
